----------------------------------------------------------------------------------------------------------------------------------- Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: Results from a randomised, dose-finding study (DARWIN 1) |
Westhovens Rene12, Taylor Peter Charles3, Alten Rieke E.E.4, Pavlova Dace5, Enriquez-Sosa F.6, Mazur Minodora7, Greenwald Maria W.8, Van Der Aa Annegret9, Vanhoutte Frederic P.9, Tasset Chantal9, Harrison Pille9 |
1 Catholic University of Leuven (KU Leuven), 3 University of Oxford, 7 Institute of Cardiology,
|
Annals of the Rheumatic Diseases |
Nr. / 2017 / ISSN - /ISSNe 0003-4967 |
Disponibil online 20 February, 2018. Descarcări-0. Vizualizări-908 |
----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-20 of 34